TTS Ltd. and the
Wellcome Trust will be holding its 2013 edition of TTS Europe on July 1-2, 2013
at the Welcome Trust in London, UK. The
TTS Global Initiative is the leading international meeting for biotech sector Industry-academia
licensing, partnering, and technology transfer.
TTS Europe is not an IP Counsel meeting, but a multi-stakeholder meeting
where IP and early-stage biotech are front and center and where Tech Transfer
Officers and IP professionals discuss and debate issues, models, and strategy
directly with other key stakeholders in early-stage biotech and bio-pharma
innovation.
A full program for TTS Europe, including an agenda of each event's sessions and list of speakers can be obtained here. Patent Docs author Dr. Kevin Noonan of McDonnell Boehnen Hulbert & Berghoff LLP will provide a presentation on "The most important trends & developments in global biotech IP, or what the hell is happening in the US?"
The registration fee for TTS Europe is £599 (academic Innovators, university or Institute Technology Transfer Officers, non-governmental or non-profit organizations, and start-ups) or £999 (multinational, corporate, legal & consulting, and government). Patent Docs readers who register using the Code CJS13 will be able to secure a reduced registration fee of £399 (academic Innovators, university or Institute Technology Transfer Officers, non-governmental or non-profit organizations, and start-ups) or £699 (multinational, corporate, legal & consulting, and government). Details regarding registration for the event can be found here.
Patent Docs and McDonnell Boehnen Hulbert & Berghoff LLP are partners of TTS Europe.
Comments